SENS PubMed Publication Search
Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.
Nat Med. 2013 Sep;19(9):1111-3. doi: 10.1038/nm.3261
Bacman SR, Williams SL, Pinto M, Peralta S, Moraes CT
Abstract:
.....We have engineered transcription activator-like effector nucleases (TALENs) to localize to mitochondria and cleave different classes of pathogenic mtDNA mutations. Mitochondria-targeted TALEN (mitoTALEN) expression led to permanent reductions in deletion or point-mutant mtDNA in patient-derived cells, raising the possibility that these mitochondrial nucleases can be therapeutic for some mitochondrial diseases.
PMID: 23913125
Tags: mitoTALENs